Biomarker Discovery and Molecular Docking Reveal Marsdenia tenacissima Fermentation Product’s Anti-Lung Cancer Components
Open Access
- 6 June 2025
- journal article
- research article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (6) , 427
Abstract
In traditional Chinese medicine, Marsdenia tenacissima is employed to prevent and treat lung cancer. The anti-tumor properties are further amplified by the fermentation product of Ganoderma lucidum and Marsdenia tenacissima (MGF). Nevertheless, the efficacy of the chemical components in combating lung cancer and the potential therapeutic targets for treating the disease remain ambiguous. UPLC-Q-TOF/MS was used to identify 19 components, all of which are unique C21 steroidal saponins found in MGF. The analysis of network pharmacology indicated that the active targets of these components were significantly concentrated in lung cancer and had a strong connection with cell proliferation. The bioinformatics analysis was conducted on data from TCGA and DisGeNET to identify a total of 28 biomarkers. Furthermore, our findings showed that the 19 targets connected to the active ingredients of Marsdenia tenacissima demonstrated significant enrichment in both the EGFR and apoptosis signaling pathways. Molecular docking technology was utilized to confirm the binding interactions of the primary constituents with the designated target.Keywords
This publication has 25 references indexed in Scilit:
- Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based studyThe Lancet Respiratory Medicine, 2025
- Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancerPhytomedicine, 2021
- Traditional Chinese medicine and lung cancer——From theory to practiceBiomedicine & Pharmacotherapy, 2021
- RAS as a positive predictive biomarker: focus on lung and colorectal cancer patientsEuropean Journal of Cancer, 2021
- Radix Tetrastigma Inhibits the Non-Small Cell Lung Cancer via Bax/Bcl-2/Caspase-9/Caspase-3 PathwayNutrition and Cancer, 2021
- Mechanism of Marsdenia tenacissima extract promoting apoptosis of lung cancer by regulating Ca2+/CaM/CaMK signalingJournal of Ethnopharmacology, 2020
- Tenacigenin B ester derivatives from Marsdenia tenacissima actively inhibited CYP3A4 and enhanced in vivo antitumor activity of paclitaxelJournal of Ethnopharmacology, 2019
- P2.04-12 A Genomic Signature [JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2] Predicts Baseline Resistance to Nivolumab in Advanced NSCLC.Journal of Thoracic Oncology, 2018
- Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC)Bioorganic & Medicinal Chemistry Letters, 2014
- Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosisMedical Oncology, 2010